mirror of
https://github.com/msberends/AMR.git
synced 2024-12-26 06:06:12 +01:00
update navbar colours
This commit is contained in:
parent
46634bfcaa
commit
f2d245b0cb
@ -1,6 +1,6 @@
|
||||
Package: AMR
|
||||
Version: 2.1.1.9012
|
||||
Date: 2024-02-25
|
||||
Version: 2.1.1.9013
|
||||
Date: 2024-03-03
|
||||
Title: Antimicrobial Resistance Data Analysis
|
||||
Description: Functions to simplify and standardise antimicrobial resistance (AMR)
|
||||
data analysis and to work with microbial and antimicrobial properties by
|
||||
|
6
NEWS.md
6
NEWS.md
@ -1,4 +1,4 @@
|
||||
# AMR 2.1.1.9012
|
||||
# AMR 2.1.1.9013
|
||||
|
||||
*(this beta version will eventually become v3.0. We're happy to reach a new major milestone soon, which will be all about the new One Health support!)*
|
||||
|
||||
@ -165,7 +165,7 @@ The new function `add_custom_antimicrobials()` allows users to add custom antimi
|
||||
|
||||
The `antibiotics` data set was greatly updated:
|
||||
|
||||
* The following 20 antibiotics have been added (also includes the [new J01RA ATC group](https://www.whocc.no/atc_ddd_index/?code=J01RA&showdescription=no)): azithromycin/fluconazole/secnidazole (AFC), cefepime/amikacin (CFA), cefixime/ornidazole (CEO), ceftriaxone/beta-lactamase inhibitor (CEB), ciprofloxacin/metronidazole (CIM), ciprofloxacin/ornidazole (CIO), ciprofloxacin/tinidazole (CIT), furazidin (FUR), isoniazid/sulfamethoxazole/trimethoprim/pyridoxine (IST), lascufloxacin (LSC), levofloxacin/ornidazole (LEO), nemonoxacin (NEM), norfloxacin/metronidazole (NME), norfloxacin/tinidazole (NTI), ofloxacin/ornidazole (OOR), oteseconazole (OTE), rifampicin/ethambutol/isoniazid (REI), sarecycline (SRC), tetracycline/oleandomycin (TOL), and thioacetazone (TAT)
|
||||
* The following 20 antibiotics have been added (also includes the [new J01RA ATC group](https://atcddd.fhi.no/atc_ddd_index/?code=J01RA&showdescription=no)): azithromycin/fluconazole/secnidazole (AFC), cefepime/amikacin (CFA), cefixime/ornidazole (CEO), ceftriaxone/beta-lactamase inhibitor (CEB), ciprofloxacin/metronidazole (CIM), ciprofloxacin/ornidazole (CIO), ciprofloxacin/tinidazole (CIT), furazidin (FUR), isoniazid/sulfamethoxazole/trimethoprim/pyridoxine (IST), lascufloxacin (LSC), levofloxacin/ornidazole (LEO), nemonoxacin (NEM), norfloxacin/metronidazole (NME), norfloxacin/tinidazole (NTI), ofloxacin/ornidazole (OOR), oteseconazole (OTE), rifampicin/ethambutol/isoniazid (REI), sarecycline (SRC), tetracycline/oleandomycin (TOL), and thioacetazone (TAT)
|
||||
* Added some missing ATC codes
|
||||
* Updated DDDs and PubChem Compound IDs
|
||||
* Updated some antibiotic name spelling, now used by WHOCC (such as cephalexin -> cefalexin, and phenethicillin -> pheneticillin)
|
||||
@ -178,7 +178,7 @@ Also, we added support for using antibiotic selectors in scoped `dplyr` verbs (w
|
||||
|
||||
We now added extensive support for antiviral agents! For the first time, the `AMR` package has extensive support for antiviral drugs and to work with their names, codes and other data in any way.
|
||||
|
||||
* The `antivirals` data set has been extended with 18 new drugs (also from the [new J05AJ ATC group](https://www.whocc.no/atc_ddd_index/?code=J05AJ&showdescription=no)) and now also contains antiviral identifiers and LOINC codes
|
||||
* The `antivirals` data set has been extended with 18 new drugs (also from the [new J05AJ ATC group](https://atcddd.fhi.no/atc_ddd_index/?code=J05AJ&showdescription=no)) and now also contains antiviral identifiers and LOINC codes
|
||||
* A new data type `av` (*antivirals*) has been added, which is functionally similar to `ab` for antibiotics
|
||||
* Functions `as.av()`, `av_name()`, `av_atc()`, `av_synonyms()`, `av_from_text()` have all been added as siblings to their `ab_*()` equivalents
|
||||
|
||||
|
BIN
R/sysdata.rda
BIN
R/sysdata.rda
Binary file not shown.
@ -29,18 +29,30 @@
|
||||
# ==================================================================== #
|
||||
*/
|
||||
|
||||
:root {
|
||||
--bs-primary: #128F76 !important;
|
||||
--bs-primary-color: #128F76 !important;
|
||||
--bs-primary-rgb: 18, 143, 118 !important;
|
||||
|
||||
--bs-secondary: #a7dbc3 !important;
|
||||
--bs-secondary-color: #a7dbc3 !important;
|
||||
--bs-secondary-rgb: 167, 219, 195 !important;
|
||||
|
||||
:root, .navbar * {
|
||||
--bs-primary: #a7dbc3 !important;
|
||||
--bs-primary-color: #a7dbc3 !important;
|
||||
--bs-primary-rgb: 167, 219, 195 !important;
|
||||
--bs-secondary: #ffffff !important;
|
||||
--bs-secondary-color: #ffffff !important;
|
||||
--bs-secondary-rgb: 255, 255, 255 !important;
|
||||
--bs-navbar-brand-color: var(--bs-body-color) !important;
|
||||
--bs-navbar-brand-color-hover: var(--bs-body-color) !important;
|
||||
--bs-nav-link-color: var(--bs-body-color) !important;
|
||||
--bs-bg-opacity: 1 !important;
|
||||
}
|
||||
.nav-text.text-muted {
|
||||
color: var(--bs-success) !important;
|
||||
}
|
||||
|
||||
.template-home img.logo {
|
||||
width: 200px;
|
||||
}
|
||||
@media (max-width: 575.98px) {
|
||||
.template-home img.logo {
|
||||
width: 140px;
|
||||
}
|
||||
}
|
||||
/* fix some footer issues with the logos */
|
||||
@media (min-width: 576px) {
|
||||
footer .pkgdown-footer-right {
|
||||
|
Loading…
Reference in New Issue
Block a user